Bacteria Gene Editing Medicine Reagent 
Drug Discovery World
JULY 18, 2023
Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. These efforts, along with many others, are opening doors for new possibilities in translational medicine. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,
The Pharma Data
DECEMBER 2, 2020
aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. The new “pathoblocker” treatment aims to disarm pathogens and suppress the disease-causing properties of P.
Expert insights. Personalized for you.
98 
Let's personalize your content